Qrxpharma Limited

Ord Minnett View

You need to become a client or login to see Forsyth Barr’s current view.

Recent research View all research

About Qrxpharma Limited

QRxPharma Limited (QRX) is a commercial-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders. The Company's product portfolio includes both late and early stage clinical drug candidates. QRX conducts its operations in Australia, with the main focus on MoxDuo (Morphine & Oxycodones) product.

Forsyth Barr Analyst

Share price performance

All stock prices and news delayed 20 minutes

19:39 December 19th 2018 NZDT

0.03 0.0%

-- Buy

-- Sell

Last --

Open --

High --

Low --

Volume -

Turnover -

Most recent trades All trades for the day

Time Price Volume Value

Latest Qrxpharma Limited research

Today's trades

Trade Number Time Price Volume Value
If you're new to investing or just have a question please call us: 0800 367 227